Clinical trialNCT02985021TerminatedPhase 2Interventional

Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies

SponsorSeattle Institute for Biomedical and Clinical ResearchEnrollment2Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

In this study, patients who have metastatic prostate cancer that does not respond to hormone treatment and who have mutations in certain cancer-related genes will be treated with docetaxel and carboplatin chemotherapy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Matthew Rettig, MD
VA Greater Los Angeles HCS
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Robert B Montgomery, MD
VA Puget Sound HCS
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Va Greater Los Angeles - West la
Los Angeles, California, United States
Va Ann Arbor Health Care System
Ann Arbor, Michigan, United States
Va Puget Sound Health Care System
Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Carboplatin →Docetaxel →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2016
Primary completion: 30 Apr 2021
Completion: 30 Apr 2021
Last update posted: 5 Aug 2021
Registered enrollment: 2
Registry id: NCT02985021

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.